Associations of choroid plexus volume with white matter hyperintensity volume and susceptibility and plasma amyloid markers in cerebral small vessel disease
Open accessThe DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND: White matter hyperintensity (WMH) is a key feature of cerebral small vessel disease (CSVD). The impact of the choroid plexus (CP) volume on disease progression remains largely unexplored. This study evaluated the relationship between CP volume and CSVD severity via WMH volume and susceptibility values. Additionally, we explored whether Alzheimer's disease (AD)-related plasma proteins influence the volume of the CP. METHODS AND MATERIALS: Our study included 291 CSVD individuals, with 84 participants completing subsequent brain MRI at a mean follow-up of 20 months. To explore the potential CP-associated pathways, we assessed the relationships between AD-related plasma biomarkers and CP volume via multiple linear regression analysis. The longitudinal associations between CP volume and WMH characteristics (WMH volume and susceptibility) were analyzed via linear mixed-effects models. Finally, we employed random forest analysis with the Boruta algorithm to identify key predictors of CSVD severity. RESULTS: Plasma Aβ1‒40 levels were positively correlated with CP volume (β = 0.115, P = 0.009), whereas Aβ42‒40 ratio were negatively associated with CP volume (β = -0.135, P = 0.03). Notably, increased CP volume was associated with both greater WMH burden (β = 0.191, P = 0.011) and decreased WMH susceptibility (β = -0.192, P = 0.012). Furthermore, random forest modeling identified CP volume and WMH susceptibility as the strongest predictors of CSVD severity. CONCLUSIONS: CP volume changes were significantly correlated with both WMH volume and WMH susceptibility in CSVD patients. These findings suggest that CP-mediated pathways may link amyloid metabolism to CSVD progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging
Fazekas, F., Chawluk, J., Alavi, A., Hurtig, H., & Zimmerman, R. (1987) · American Journal of Roentgenology · doi:10.2214/ajr.149.2.351 · Cited by 5,334 · cited 1×
“Specifically, one point was assigned for each of the following: presence of ≥ 1 lacunar infarct; early confluent deep WMH (Fazekas score [17] 2 or 3) or irregular periventricular WMH extending into deep white matter (Fazekas score 3); moderate to severe (grade 2–3) enlarged perivascular spaces in…”
fMRIPrep: A robust preprocessing pipeline for functional MRI
Esteban, O., Markiewicz, C. J., Blair, R. W., Moodie, C. A., Isik, A. I., Erramuzpe, A., Kent, J. D., Goncalves, M., DuPre, E., Snyder, M., et al. (2019) · Nature Methods · doi:10.1038/s41592-018-0235-4 · Cited by 3,905 · cited 1×
“The structural MRI data were preprocessed via fMRIPrep 20.1.1, which generated a nonlinear deformation field mapping native space to the MNI2009c space [18].”
InfluentialSmall vessel disease: mechanisms and clinical implications
Wardlaw, J. M., Smith, C., & Dichgans, M. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30079-1 · Cited by 1,777 · cited 1×
“Cerebral small vessel disease (CSVD) has emerged as a significant health challenge among aging populations globally, contributing to cognitive impairment, increased incidence of stroke, and disability [1, 2].”
The role of brain vasculature in neurodegenerative disorders
Sweeney, M. D., Kisler, K., Montagne, A., Toga, A. W., & Zlokovic, B. V. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0234-x · Cited by 998 · cited 1×
“White matter hyperintensities (WMHs), recognized as pivotal imaging indicators of CSVD, are closely linked to unfavorable clinical outcomes, such as cognitive dysfunction and increased stroke risk [3, 4].”
Debette, S., Schilling, S., Duperron, M.-G., Larsson, S. C., & Markus, H. S. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2018.3122 · Cited by 717
Development and functions of the choroid plexus–cerebrospinal fluid system
Lun, M. P., Monuki, E. S., & Lehtinen, M. K. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3921 · Cited by 678 · cited 2×
“Recent studies have shown a relationship between changes in CP volume and neurodegenerative disorders [6].”
Understanding the role of the perivascular space in cerebral small vessel disease
Brown, R., Benveniste, H., Black, S. E., Charpak, S., Dichgans, M., Joutel, A., Nedergaard, M., Smith, K. J., Zlokovic, B. V., & Wardlaw, J. M. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy113 · Cited by 336
Choroid Plexus Volume and Permeability at Brain MRI within the Alzheimer Disease Clinical Spectrum
Choi, J. D., Moon, Y., Kim, H.-J., Yim, Y., Lee, S., & Moon, W.-J. (2022) · Radiology · doi:10.1148/radiol.212400 · Cited by 266 · cited 2×
“These CP-related changes are hypothesized to exacerbate disease progression by disrupting CSF dynamics and hindering the clearance of neurotoxic substances [8].”
Klarenbeek, P., van Oostenbrugge, R. J., Rouhl, R. P. W., Knottnerus, I. L. H., & Staals, J. (2013) · Stroke · doi:10.1161/strokeaha.113.002545 · Cited by 248 · cited 1×
“CSVD severity was evaluated using a comprehensive scoring system that assesses the total burden of small vessel disease [15, 16].”
Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications
Bartzokis, G., Lu, P. H., Tishler, T. A., Fong, S. M., Oluwadara, B., Finn, J. P., Huang, D., Bordelon, Y., Mintz, J., & Perlman, S. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9352-7 · Cited by 238 · cited 1×
“Abbreviations: CSVD = cerebral small vessel disease; CP/ICV = choroid plexus volume normalized to the intracranial volume; WMH = white matter hyperintensity WMH susceptibility values might indicate iron loss or redistribution, which is consistent with myelin damage and nerve fiber injury [29].”
Cited by
Luo, L., & Qiao, S. (2026) · European journal of medical research · doi:10.1186/s40001-026-03840-z · Cited by 28
“Notably, increased ChP volume correlates with CSVD severity [93].”
Xu, X., Zhou, X., Zhang, M., Fang, J., Yan, Z., Zhu, X., Yu, Y., & Zhu, J. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71201 · Cited by 12
Xu, M., Zhang, B., Mao, H., Shi, Y., Ma, L., Yang, J., Li, M., Wang, F., Wang, H., & Fang, X. (2025) · Neuroradiology · doi:10.1007/s00234-025-03836-2 · Cited by 4
Self-citationLi, L., Pan, P., Li, J., Tang, M., Zhang, D., Lei, X., Zhang, X., & Gao, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1838132 · Cited by 2
“Earlier research has associated CP enlargement with WMH burden and cognitive issues in cerebral small vessel disease (CSVD), supporting the biological plausibility of CP-related in fl ammatory and CSF-interface involvement (41).”
Luo, D., Wang, X., Peng, Y., Zeng, P., Zeng, B., Li, B., Nie, L., Luo, T., & Li, Y. (2026) · Neuroradiology · doi:10.1007/s00234-026-03922-z · Cited by 1
“In vivo MRI studies have reported increased CP volume in patients with CSVD imaging mark - ers [ 10, 12], and such enlargement has been interpreted as reflecting stromal expansion, epithelial remodeling, and low-grade inflammation.”
Influential
Metadata
- Authors
- Liang, P., Li, M., Chen, Y., Cheng, Z., Wang, N., Wang, Y., Zhang, N., Che, Y., Li, J., Liang, C., & Guo, L.
- Affiliations
- Shandong Provincial Hospital (CN)
- Jena University Hospital (DE)
- Binzhou Medical University (CN)
- Beijing Tsinghua Chang Gung Hospital (CN)
- Corresponding author
- Li, Jing
- Liang, Changhu
- Guo, Lingfei
- ORCID
- Venue
- Alzheimer's Research & Therapy
- Published
- 2025-04-23
- Volume
- 17
- Issue
- 1
- Pages
- 90-90
- ISSN
- 1758-9193 (ISSN-L)
- PMC
- PMC12016351
- OpenAlex
- W4409709743
- Cited by
- 13
- References
- 34
- Citations by year
- 2026: 10 · 2025: 3
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Alzheimer s Research & Therapy (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Common Library Network (Der Gemeinsame Bibliotheksverbund) (submittedVersion, cc-by-nc-nd)
- Funders
- Natural Science Foundation of Shandong Province (ZR2024MH026, ZR2020MH288)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Keywords
- choroid plexus volume, cerebral small vessel disease, white matter hyperintensities, amyloid-beta, Aβ40, Aβ42/Aβ40 ratio, Alzheimer's disease, amyloid metabolism
- MeSH terms
- Aged, Aged, 80 and over, Choroid Plexus, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Peptide Fragments, Biomarkers, Amyloid beta-Peptides, Disease Progression, Cerebral Small Vessel Diseases, White Matter
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Associations of choroid plexus volume with white matter hyperintensity volume and susceptibility and plasma amyloid markers in cerebral small vessel disease. https://app.cochat.ai/papers/10.1186/s13195-025-01740-8
- The paper
- Liang, P., Li, M., Chen, Y., Cheng, Z., Wang, N., Wang, Y., Zhang, N., Che, Y., Li, J., Liang, C., & Guo, L. (2025). Associations of choroid plexus volume with white matter hyperintensity volume and susceptibility and plasma amyloid markers in cerebral small vessel disease. Alzheimer's Research & Therapy. https://doi.org/10.1186/s13195-025-01740-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.